Voice Handicap Index (VHI)
The Voice Handicap Index is a validated, self-administered patient-reported outcome measure that quantifies the impact of a voice disorder on a person's quality of life and daily functioning.
Background & Purpose
Developed by Jacobson et al. (1997), the VHI captures the patient's own perception of how dysphonia affects routine living. It is one of the most widely used voice questionnaires globally and has been translated and validated in numerous languages.
Structure
The full VHI has 30 items divided into three equal subscales of 10 questions each:
| Subscale | What It Measures |
|---|
| Functional (F) | Impact on daily activities - e.g., difficulty being heard, reduced social/professional communication |
| Physical (P) | Vocal symptoms themselves - e.g., breathiness, hoarseness, vocal fatigue, effort |
| Emotional (E) | Affective responses to the voice disorder - e.g., embarrassment, anxiety, feeling handicapped |
Each item is rated on a 5-point Likert scale:
- 0 = Never
- 1 = Almost Never
- 2 = Sometimes
- 3 = Almost Always
- 4 = Always
Scoring & Interpretation
Total score range: 0 to 120
| Score | Severity |
|---|
| < 40 | Mild or no disability |
| 40 - 60 | Moderate disability |
| > 60 | Severe disability |
Each subscale scores 0-40. Subscale scores can identify which domain (functional, physical, or emotional) is most affected.
Abbreviated Form: VHI-10
The VHI-10 (Rosen et al., 2004) is a 10-item short form with a score range of 0 to 40. It is the single most commonly used patient-reported outcome measure in US voice clinics, due to its brevity while retaining sensitivity. Severity bands per Arffa et al. (2012) are used in most clinics to interpret the raw score.
There is also a Singing Voice Handicap Index (SVHI/SVHI-10) for professional or recreational singers.
Clinical Applications
The VHI is used for:
- Baseline assessment of perceived voice handicap at the initial clinic visit
- Outcome measurement after voice therapy, phonosurgery, laryngeal injection, radiation, or chemoradiotherapy
- Comparative studies across treatment modalities (e.g., transoral laser excision vs. radiotherapy for early glottic cancer, supracricoid partial laryngectomy, alaryngeal voice restoration)
- Monitoring disease progression in chronic laryngeal conditions
It is used alongside objective tools including:
- Stroboscopy / videolaryngoscopy
- Acoustic voice analysis
- GRBAS perceptual rating scale (Grade, Roughness, Breathiness, Asthenia, Strain)
- CAPE-V (Consensus Auditory-Perceptual Evaluation of Voice)
- Aerodynamic measurements
Other Voice-Specific PRO Measures (for comparison)
| Tool | Items | Notes |
|---|
| VHI | 30 | Gold standard; F, P, E subscales |
| VHI-10 | 10 | Most widely used in US clinics |
| V-RQOL | 10 | Voice-related quality of life |
| VoiSS | 30 | Impairment + emotional + physical symptoms; strong psychometrics |
| VAPP | 28 | Visual analogue scale; 5 domains |
| VPQ | 12 | Brief; frequently used in UK |
| SVHI-10 | 10 | Singing-specific |
Important Limitations
- The VHI measures perceived handicap, not severity of the voice disorder itself. A patient with mild objective dysphonia may score high if psychosocially affected, and vice versa.
- It should not be used as a standalone diagnostic or screening tool. It requires correlation with clinical examination (laryngoscopy) and perceptual ratings.
- A 2026 systematic review and meta-analysis (PMID: 37778959) assessed the internal consistency of the VHI across dysphonic populations, supporting its reliability as a measurement instrument.
Sources: Scott-Brown's Otorhinolaryngology Head & Neck Surgery; K.J. Lee's Essential Otolaryngology, p. 918